Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Filippo Migliorini, Giovanni Asparago, Francesco Oliva, Francesco Cuozzo & Nicola Maffulli. (2022) A comprehensive update on the pharmacological management of heterotopic ossification following hip arthroplasty: a level I evidenced based expert opinion. Expert Opinion on Pharmacotherapy 23:10, pages 1195-1203.
Read now
Read now
Barbara Lisowska, Dariusz Kosson & Karolina Domaracka. (2018) Positives and negatives of nonsteroidal anti-inflammatory drugs in bone healing: the effects of these drugs on bone repair. Drug Design, Development and Therapy 12, pages 1809-1814.
Read now
Read now
Sigbjørn Dimmen. (2011) Effects of cox inhibitors on bone and tendon healing. Acta Orthopaedica 82:sup342, pages 1-22.
Read now
Read now
Robert J Macfarlane, Boon Han Ng, Zakareya Gamie, Mohamed A El Masry, Stylianos Velonis, Constantin Schizas & Eleftherios Tsiridis. (2008) Pharmacological treatment of heterotopic ossification following hip and acetabular surgery. Expert Opinion on Pharmacotherapy 9:5, pages 767-786.
Read now
Read now
Articles from other publishers (27)
Jens Schneider, Nicola Maffulli, Jörg Eschweiler, Andreas Bell, Frank Hildebrand & Filippo Migliorini. (2023) Efficacy of ibuprofen and indomethacin as prophylaxis of heterotopic ossification: a comparative study. Scientific Reports 13:1.
Crossref
Crossref
Michael Fuchs & Heiko Reichel. 2020. AE-Manual der Endoprothetik. AE-Manual der Endoprothetik
1
8
.
Filippo Migliorini, Andrea Pintore, Alice Baroncini, Torsten Pastor, Frank Hildebrand & Nicola Maffulli. (2022) Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: a meta-analysis. Journal of Orthopaedics and Traumatology 23:1.
Crossref
Crossref
Jacob Shapira, Mitchell J Yelton, Jeffery W Chen, Philip J Rosinsky, David R Maldonado, Mitchell Meghpara, Ajay C Lall & Benjamin G Domb. (2021) Efficacy of NSAIDs versus radiotherapy for heterotopic ossification prophylaxis following total hip arthroplasty in high-risk patients: a systematic review and meta-analysis. HIP International 32:5, pages 576-590.
Crossref
Crossref
Changsheng Pu & Yuxi Su. (2021) Are open surgery and total resection good choices for traumatic myositis ossificans in children?. International Orthopaedics 45:12, pages 3147-3154.
Crossref
Crossref
Ki Kwang Oh, Md. Adnan & Dong Ha Cho. (2021) Network pharmacology approach to decipher signaling pathways associated with target proteins of NSAIDs against COVID-19. Scientific Reports 11:1.
Crossref
Crossref
Filippo Migliorini, Andromahi Trivellas, Jörg Eschweiler, Arne Driessen, Markus Tingart & Nicola Maffulli. (2020) NSAIDs for Prophylaxis for Heterotopic Ossification After Total Hip Arthroplasty: A Bayesian Network Meta-analysis. Calcified Tissue International 108:2, pages 196-206.
Crossref
Crossref
Paweł Łęgosz, Maciej Otworowski, Aleksandra Sibilska, Krzysztof Starszak, Daniel Kotrych, Adam Kwapisz & Marek Synder. (2019) Heterotopic Ossification: A Challenging Complication of Total Hip Arthroplasty: Risk Factors, Diagnosis, Prophylaxis, and Treatment. BioMed Research International 2019, pages 1-8.
Crossref
Crossref
Elissa C. Zakrasek, Shara M. Yurkiewicz, Ben Dirlikov, B. Tim Pence & James D. Crew. (2018) Use of nonsteroidal anti-inflammatory drugs to prevent heterotopic ossification after spinal cord injury: a retrospective chart review. Spinal Cord 57:3, pages 214-220.
Crossref
Crossref
Liyang Cai, Zhan Wang, Xiangli Luo, Wei She & Hui Zhang. (2019) Optimal strategies for the prevention of heterotopic ossification after total hip arthroplasty: A network meta-analysis. International Journal of Surgery 62, pages 74-85.
Crossref
Crossref
M. JoiceG. I. VasileiadisD. F. Amanatullah. (2018) Non-steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty. The Bone & Joint Journal 100-B:7, pages 915-922.
Crossref
Crossref
Peter B. White, Prem N. Ramkumar, Morteza Meftah, Narges Ghazi, Amar S. Ranawat & Chitranjan S. Ranawat. (2018) Incidence of Heterotopic Ossification Following a Multimodal Pain Protocol in Total Hip Arthroplasty With the Posterior Approach. Orthopedics 41:1.
Crossref
Crossref
Liang Cheng, Hai-Tao Long, Bu-Hua Sun, Shu-shan Zhao & Yong Zhu. (2017) The efficacy of a multimodal analgesia protocol in preventing heterotopic ossification after acetabular fractures surgery. International Journal of Clinical Pharmacy 39:4, pages 826-830.
Crossref
Crossref
Avadhoot P. KantakNirav N. Shah. (2017) Extensive Surgical Wound Lavage Reduces the Incidence and Severity of Heterotopic Ossification in Primary Total Hip Replacement: A Study of 175 Hip Replacements. Hip & Pelvis 29:4, pages 234.
Crossref
Crossref
Shun-Li Kan, Bo Yang, Guang-Zhi Ning, Ling-Xiao Chen, Yu-Lin Li, Shi-Jie Gao, Xing-Yu Chen, Jing-Cheng Sun & Shi-Qing Feng. (2015) Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty. Medicine 94:18, pages e828.
Crossref
Crossref
Sivanadian Mani-Babu, Roger Wolman & Richard Keen. (2014) Quadriceps Traumatic Myositis Ossificans in a Football Player. Clinical Journal of Sport Medicine 24:5, pages e56-e58.
Crossref
Crossref
Carlos J. Lavernia, Juan S. Contreras, Jesus M. Villa & Mark D. Rossi. (2014) Celecoxib and Heterotopic Bone Formation After Total Hip Arthroplasty. The Journal of Arthroplasty 29:2, pages 390-392.
Crossref
Crossref
Jaap J. Brunnekreef & Berend W. Schreurs. (2013) Response to comment on Brunnekreef et al.: Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?. International Orthopaedics 37:8, pages 1631-1631.
Crossref
Crossref
Jaap J. Brunnekreef, Paul Hoogervorst, Marieke J. Ploegmakers, Wim H. Rijnen & Berend W. Schreurs. (2013) Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?. International Orthopaedics 37:4, pages 583-587.
Crossref
Crossref
Torrance A. Walker & William M. Mihalko. (2012) Avoiding and Treating Heterotopic Ossification After Total Hip Arthroplasty. Seminars in Arthroplasty 23:3, pages 128-134.
Crossref
Crossref
George I. Vasileiadis, Ioannis C. Sioutis, Andreas F. Mavrogenis, Konstantinos Vlasis, George C. Babis & Panayiotis J. Papagelopoulos. (2011) COX-2 Inhibitors for the Prevention of Heterotopic Ossification After THA. Orthopedics 34:6, pages 467-472.
Crossref
Crossref
Deting Xue, Qiang Zheng, Hang Li, Shengjun Qian, Bo Zhang & Zhijun Pan. (2009) Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials. International Orthopaedics 35:1, pages 3-8.
Crossref
Crossref
Patrick Narchi. (2010) Anesthésiques locaux, anti-inflammatoires, fonction cartilagineuse et cicatrisation osseuse. Le Praticien en Anesthésie Réanimation 14:5, pages 293-296.
Crossref
Crossref
Evan O Baird & Qian K Kang. (2009) Prophylaxis of heterotopic ossification – an updated review. Journal of Orthopaedic Surgery and Research 4:1.
Crossref
Crossref
Hung-Chang Chen, Jui-Yung Yang, Shiow-Shuh Chuang, Chun-Yuan Huang & Shih-Yi Yang. (2009) Heterotopic ossification in burns: Our experience and literature reviews. Burns 35:6, pages 857-862.
Crossref
Crossref
Emilios E. Pakos, Kosmas S. Stafilas, Pericles G. Tsekeris, Aggelos N. Politis, Gregory Mitsionis & Theodore A. Xenakis. (2009) Combined Radiotherapy and Indomethacin for the Prevention of Heterotopic Ossification after Total Hip ArthroplastyKombination von Radiotherapie und Indometacin zur Prävention heterotoper Ossifikationen nach Implantation einer Hüfttotalendoprothese. Strahlentherapie und Onkologie 185:8, pages 500-505.
Crossref
Crossref
Katriina Vuolteenaho, Teemu Moilanen & Eeva Moilanen. (2007) Non-Steroidal Anti-Inflammatory Drugs, Cyclooxygenase-2 and the Bone Healing Process. Basic & Clinical Pharmacology & Toxicology 0:0, pages 071031053307004-???.
Crossref
Crossref